Malave Luis has filed 21 insider transactions across 1 company since September 2021.
Most recent transaction: a grant/award of 35 shares of Glucotrack, Inc. ($GCTK) on March 25, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 35 | $0.00 | 2,395.0000 | 0 | 1.48% | 0.00% |
| July 11, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 1200 | $0.00 | 3,595.0000 | 25,585,853 | 50.10% | 0.00% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 463 | $0.00 | 4,058.0000 | 25,585,853 | 12.88% | 0.00% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| Oct. 4, 2022 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 44 | $0.00 | 122.0000 | 0 | 56.41% | 0.00% |
| Jan. 9, 2023 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 29 | $0.00 | 151.0000 | 0 | 23.77% | 0.00% |
| April 20, 2023 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 121 | $0.00 | 272.0000 | 0 | 80.13% | 0.00% |
| Dec. 31, 2023 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 362 | $0.00 | 634.0000 | 0 | 133.09% | 0.00% |
| April 8, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 489 | $0.00 | 1,123.0000 | 0 | 77.13% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | C | Common Stock, par value $0.001 per share | 6886 | $31.20 | 8,009.0000 | 0 | 613.18% | 0.00% |
| Sept. 30, 2021 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 8 | $0.00 | 8.0000 | 0 | 9999.99% | 0.00% |
| March 26, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 2076 | $0.00 | 143,617.0000 | 0 | 1.47% | 0.00% |
| July 18, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | P | Convertible Promissory Note | 200000 | $200000.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | C | Convertible Promissory Note | 214831 | $214831.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Series A Common Warrant | 6886 | $0.00 | 6,886.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Series B Common Warrant | 6886 | $0.00 | 6,886.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | X | Series B Common Warrant | 6886 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | X | Common Stock, par value $0.001 per share | 133532 | $0.00 | 141,541.0000 | 0 | 1667.27% | 0.00% |
| Dec. 31, 2021 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 11 | $0.00 | 19.0000 | 0 | 137.50% | 0.00% |
| March 31, 2022 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 25 | $0.00 | 44.0000 | 0 | 131.58% | 0.00% |
| June 30, 2022 | Glucotrack, Inc. | $GCTK | Malave Luis | Director | A | Common Stock, par value $0.001 per share | 34 | $0.00 | 78.0000 | 0 | 77.27% | 0.00% |